Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9315)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jul 21, 2020 (publication date) through Dec 1, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yao QY, Feng YD, Han P, Yang F, Song GQ. Hepatic microenvironment underlies fibrosis in chronic hepatitis B patients. World J Gastroenterol 2020; 26(27): 3917-3928 [PMID: 32774066 DOI: 10.3748/wjg.v26.i27.3917] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v26/i27/3917.htm |
| Number | Citing Articles |
| 1 |
Qian Liu, Jiajia Li, Xin Li, Li Zhang, Shun Yao, Yongfeng Wang, Biguang Tuo, Hai Jin. Advances in the understanding of the role and mechanism of action of PFKFB3‑mediated glycolysis in liver fibrosis (Review). International Journal of Molecular Medicine 2024; 54(6) doi: 10.3892/ijmm.2024.5429
|
| 2 |
Yusheng Guo, Guohui Wu, Junrong Yi, Qin Yang, Wengong Jiang, Shaoqiang Lin, Xiaorong Yang, Xiangsheng Cai, Liufeng Mao. Anti-Hepatocellular Carcinoma Effect and Molecular Mechanism of the Estrogen Signaling Pathway. Frontiers in Oncology 2022; 11 doi: 10.3389/fonc.2021.763539
|
| 3 |
Min Xu, Charlotte Warner, Xiaoqiong Duan, Zhimeng Cheng, Andre J. Jeyarajan, Wenting Li, Yongtao Wang, Tuo Shao, Shadi Salloum, Pei-Jer Chen, Xu Yu, Raymond T. Chung, Wenyu Lin. HIV coinfection exacerbates HBV-induced liver fibrogenesis through a HIF-1α- and TGF-β1-dependent pathway. Journal of Hepatology 2024; 80(6): 868 doi: 10.1016/j.jhep.2024.01.026
|
| 4 |
Kai Yang, Beibei Sun, Shicheng Zhang, Ying Pan, Jun Fang. RDW-SD is Superior to RDW-CV in Reflecting Liver Fibrosis Stage in Patients with Chronic Hepatitis B. Infection and Drug Resistance 2023; : 6881 doi: 10.2147/IDR.S427047
|
| 5 |
Yuhua Xie, Jing Liu, Yifan Shi, Xiaoyan Xie, Jie Yu, Ming Xu, Xiaohua Xie, Guangliang Huang, Bowen Zhuang, Mingsen Bi, Dongjie Qu, Fangying Fan, Minghua Ying, Qingqing Sun, Manxia Lin, Ping Liang. Risk factors of complications after thermal ablation for hepatocellular carcinoma: the role of assessment of liver background. European Journal of Gastroenterology & Hepatology 2024; doi: 10.1097/MEG.0000000000002879
|
| 6 |
Lei Qin, Nian Liu, Chao-le-meng Bao, Da-zhi Yang, Gui-xing Ma, Wei-hong Yi, Guo-zhi Xiao, Hui-ling Cao. Mesenchymal stem cells in fibrotic diseases—the two sides of the same coin. Acta Pharmacologica Sinica 2023; 44(2): 268 doi: 10.1038/s41401-022-00952-0
|
| 7 |
Stephen Sinclair, Sean Shearen, Youssef Ghobrial, George Trad, Syed Abdul Basit, David Shih, John K. Ryan. Review of the Effects of Antiviral Therapy on Hepatitis B/C-Related Mortality and the Regression of Fibrosis. Viruses 2024; 16(10): 1531 doi: 10.3390/v16101531
|
| 8 |
Ruohao Xu, Miao Wu, Yawen Wang, Chao Li, Lingji Zeng, Yulian Wang, Maozhi Xiao, Xiaomei Chen, Suxia Geng, Peilong Lai, Xin Du, Jianyu Weng. Mesenchymal stem cells reversibly de-differentiate myofibroblasts to fibroblast-like cells by inhibiting the TGF-β-SMAD2/3 pathway. Molecular Medicine 2023; 29(1) doi: 10.1186/s10020-023-00630-9
|
| 9 |
Hongjuan You, Xing Wang, Lihong Ma, Fulong Zhang, Huanyang Zhang, Yuxin Wang, Xiucheng Pan, Kuiyang Zheng, Fanyun Kong, Renxian Tang. Insights into the impact of hepatitis B virus on hepatic stellate cell activation. Cell Communication and Signaling 2023; 21(1) doi: 10.1186/s12964-023-01091-7
|
| 10 |
Hairong Yao, Xuan Yang, Man Yan, Xueqin Fang, Yange Wang, Hong Qi, Li Sun, Min Tang. Correlation of Serum M-CSF, CER, and TIMP-1 Levels with Liver Fibrosis in Viral Hepatitis. Computational and Mathematical Methods in Medicine 2022; 2022: 1 doi: 10.1155/2022/6736225
|
| 11 |
Qun Wang, Siyu Jia, Zihan Wang, Hui Chen, Xinyi Jiang, Yan Li, Peng Ji. Nanogene editing drug delivery systems in the treatment of liver fibrosis. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1418786
|
| 12 |
Yingying Zhang, Di Sun, Yawen Song, Qiao Ye. Candidate gene polymorphisms associated with silicosis and coal workers’ pneumoconiosis: a systematic review and meta-analysis. BMC Pulmonary Medicine 2024; 24(1) doi: 10.1186/s12890-024-03392-0
|
| 13 |
Basri Satilmis, Tevfik Tolga Sahin, Egemen Cicek, Sami Akbulut, Sezai Yilmaz. Hepatocellular Carcinoma Tumor Microenvironment and Its Implications in Terms of Anti-tumor Immunity: Future Perspectives for New Therapeutics. Journal of Gastrointestinal Cancer 2021; 52(4): 1198 doi: 10.1007/s12029-021-00725-8
|
| 14 |
Sheikh Mohammad Fazle Akbar, Mamun Al Mahtab, Osamu Yoshida, Julio Aguilar, Guillen Nieto Gerardo, Yoichi Hiasa. Development of Therapy Based on the Exploration of Biological Events Underlying the Pathogenetic Mechanisms of Chronic Hepatitis B Infection. Biomedicines 2023; 11(7): 1944 doi: 10.3390/biomedicines11071944
|